Download PDF
Der Nuklearmediziner 2010; 33(3): 145-153
DOI: 10.1055/s-0030-1262834
Niere und Prostata

© Georg Thieme Verlag KG Stuttgart · New York

Zur Messung der Nierenfunktion durch Clearancebestimmungen: Methoden und Indikationen – ein Update

Kidney Function Measured by Clearance: Methods and Indications – An UpdateE. Durand1 , R. Müller-Suur2
  • 1Universitätskrankenhaus Bicetre, Paris, Frankreich
  • 2Karolinska Institut, Danderyds Krankenhaus und Aleris Fysiologlab, Stockholm, Schweden
Further Information

Publication History

Publication Date:
10 September 2010 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Um die Nierenfunktion quantitativ zu beurteilen, gibt es viele Methoden. Meist benützen die Kliniker die simple Bestimmung des Plasmakreatinins, einige wählen jedoch die Kreatininclearance mit Urinsammlungen und andere alternative, aber indirekte Verfahren. Die Isotopenclearancebestimmungen sind jedoch im Vergleich mit allen anderen Methoden einfach durchzuführen und ergeben eine hohe Genauigkeit bei äußerst geringer Strahlenexposition. In diesem Überblick werden der Clearancebegriff, die unterschiedlichen Radiopharmaka, deren Vor- und Nachteile, die unterschiedlichen Clearancetechniken sowie die klinischen Indikationen zu Clearanceuntersuchungen besprochen. Dabei handelt es sich um ein Update eines entsprechenden Artikels, der 2003 in „Der Nuklearmediziner” publiziert wurde.

Abstract

Renal function impairment can be monitored by many tests. Measurement of plasma-creatinine level is the most used method, 24 h plasma-creatininclearance with urine collection is used by others and also other alternative but indirect methods exist. However, the use of radionuclide-clearances is by far the easiest performed method with the highest accuracy and precision and gives very low irradiation dose. In the following we will discuss the different radiopharmaceuticals in use, their plus and minus, the different clearance methods in use, their limitations and give some clinically important indications to perform clearance investigations according to consensus reports. Summarizing the use of plasma clearance of 51-Cr-EDTA after a single injection with one blood sample can be generally recommended, however with some modifications in special clinical situations, which are pointed out. Please note, that this paper is, for a significant part, an update of a previous paper published 2003 in “Der Nuklearmediziner”

Schlüsselwörter

Clearance - GFR - 51Cr-EDTA - 99mTc-MAG3

Key words

clearance - GFR - 51Cr-EDTA - 99mTc-MAG3

Literatur

  • 1 Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement.  Lancet. 1986;  1 307-310
    PubMedGoogle Scholar
  • 2 Blaufox MD, Aurell M, Bubeck B. et al . Report of the Radionuclides in Nephrourology Committee on renal clearance.  J Nucl Med. 1996;  37 1883-1890
    PubMedGoogle Scholar
  • 3 Boyd E. Growth of the surface area of the human body. In: Minnesota University of Minnesota Press; 1935: 132
    Google Scholar
  • 4 Brøchner-Mortensen J. A simple method for the determination of glomerular filtration rate.  Scand J Clin Lab Invest. 1972;  30 271-274
    CrossrefPubMedGoogle Scholar
  • 5 Brøchner-Mortensen J. Current status on assessment and measurement of glomerular filtration rate.  Clin Physiol. 1985;  5 1-17
    PubMedGoogle Scholar
  • 6 Brøchner-Mortensen J, Freund LG. Reliability of routine clearance methods for assessment of glomerular filtration rate in advanced renal insufficiency.  Scand J Clin Lab Invest. 1981;  41 91-97
    CrossrefPubMedGoogle Scholar
  • 7 Brown SC, O’Reilly PH. Iohexol clearance for the determination of glomerular filtration rate in clinical practice: evidence for a new gold standard.  J Urol. 1991;  146 675-679
    PubMedGoogle Scholar
  • 8 Bubeck B. Renal clearance determination with one blood sample: improved accuracy and universal applicability by a new calculation principle.  Semin Nucl Med. 1993;  23 73-86
    CrossrefPubMedGoogle Scholar
  • 9 Carlsen JE, Moller ML, Lund JO. et al . Comparison of four commercial Tc-99 m(Sn)DTPA preparations used for the measurement of glomerular filtration rate: concise communication.  J Nucl Med. 1980;  21 126-129
    PubMedGoogle Scholar
  • 10 Chantler C, Garnett ES, Parsons V. et al . Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA.  Clin Sci. 1969;  37 169-180
    PubMedGoogle Scholar
  • 11 Christensen AB, Groth S. Determination of 99 mTc-DTPA clearance by a single plasma sample method.  Clin Physiol. 1986;  6 579-588
    CrossrefPubMedGoogle Scholar
  • 12 Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine.  Nephron. 1976;  16 31-41
    Google Scholar
  • 13 Durand E, Prigent A. The basics of renal imaging and function studies.  Q J Nucl Med. 2002;  46 249-267
    PubMedGoogle Scholar
  • 14 Durand E, Prigent A, Gaillard J. Comparaison between 9 methods for estimation of glomerular filtration rate (G.F.R.) with simultaneous injections of 51Cr-EDTA and 99 mTc-DTPA. In: Taylor Jr A, Nally J, Thomsen H eds, Radionuclides in nephrology Reston: Society of Nuclear Medicine; 1997: 112-120
    Google Scholar
  • 15 Elwood CM, Sigman EM, Treger C. The measurement of glomerular filtration rate with 125I-sodium iothalamate (Conray).  Br J Radiol. 1967;  40 581-583
    CrossrefPubMedGoogle Scholar
  • 16 Fisher M, Veall N. Glomerular filtration rate estimation based on a single blood sample.  Br Med J. 1975;  2 542
    CrossrefPubMedGoogle Scholar
  • 17 Fleming JS. An improved equation for correcting slope-intercept measurements of glomerular filtration rate for the single exponential approximation.  Nucl Med Commun. 2007;  28 315-320
    CrossrefPubMedGoogle Scholar
  • 18 Florijn KW, Barendregt JN, Lentjes EG. et al . Glomerular filtration rate measurement by “single-shot” injection of inulin.  Kidney Int. 1994;  46 252-259
    CrossrefPubMedGoogle Scholar
  • 19 Garnett ES, Parsons V, Veall N. Measurement of glomerular filtration-rate in man using a 51Cr-edetic- acid complex.  Lancet. 1967;  1 818-819
    PubMedGoogle Scholar
  • 20 Granerus G, Aurell M, Bjure J. et al . Evaluation of unilateral kidney function in children. A comparison between renography and separate clearance.  Scand J Urol Nephrol. 1980;  14 263-267
    CrossrefPubMedGoogle Scholar
  • 21 Ham HR, Piepsz A. Estimation of glomerular filtration rate in infants and in children using a single-plasma sample method.  J Nucl Med. 1991;  32 1294-1297
    PubMedGoogle Scholar
  • 22 Hemmelgarn BR, Zhang J, Manns BJ. et al . Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate.  JAMA. 2010;  303 1151-1158
    CrossrefPubMedGoogle Scholar
  • 23 Hilson AJ, Mistry RD, Maisey MN. 99 Tcm-DTPA for the measurement of glomerular filtration rate.  Br J Radiol. 1976;  49 794-796
    CrossrefPubMedGoogle Scholar
  • 24 Huttunen K, Huttunen NP, Koivula A. et al . 99 mTc-DTPA – a useful clinical tool for the measurement of glomerular filtration rate.  Scand J Urol Nephrol. 1982;  16 237-241
    CrossrefPubMedGoogle Scholar
  • 25 Jagenburg R, Attman PO, Aurell M. et al . Determination of glomerular filtration rate in advanced renal insufficiency.  Scand J Urol Nephrol. 1978;  12 133-137
    CrossrefPubMedGoogle Scholar
  • 26 Jodal L, Brochner-Mortensen J. Reassessment of a classical single injection 51Cr-EDTA clearance method for determination of renal function in children and adults. Part I: Analytically correct relationship between total and one-pool clearance.  Scand J Clin Lab Invest. 2009;  69 305-313
    CrossrefPubMedGoogle Scholar
  • 27 Kamper AL, Nielsen SL. 51Cr-EDTA plasma clearance in severe renal failure determined by one plasma sample.  Scand J Clin Lab Invest. 1989;  49 555-559
    CrossrefPubMedGoogle Scholar
  • 28 Krutzen E, Back SE, Nilsson-Ehle I. et al . Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration rate.  J Lab Clin Med. 1984;  104 955-961
    PubMedGoogle Scholar
  • 29 Ladegaard-Pedersen HJ. Measurement of extracellular volume and renal clearance by a single injection of inulin.  Scand J Clin Lab Invest. 1972;  29 145-153
    CrossrefPubMedGoogle Scholar
  • 30 Levey AS. Use of glomerular filtration rate measurements to assess the progression of renal disease.  Semin Nephrol. 1989;  9 370-379
    PubMedGoogle Scholar
  • 31 Levey AS. Assessing the effectiveness of therapy to prevent the progression of renal disease.  Am J Kidney Dis. 1993;  22 207-214
    PubMedGoogle Scholar
  • 32 Moran JK. Technetium-99 m-EC and other potential new agents in renal nuclear medicine.  Semin Nucl Med. 1999;  29 91-101
    CrossrefPubMedGoogle Scholar
  • 33 Müller-Suur R, Durand E. Kidney Function Measured by Clearance: Methods and Indications [Nierenfunktionsbestimmungen mit Clearance: Methoden und Indikationen].  Der Nuklearmediziner. 2003;  26 181-188
    Article in Thieme ConnectPubMedGoogle Scholar
  • 34 Piepsz A, Tondeur M, Ham H. Revisiting normal (51)Cr-ethylenediaminetetraacetic acid clearance values in children.  Eur J Nucl Med Mol Imaging. 2006;  33 1477-1482
    CrossrefPubMedGoogle Scholar
  • 35 Prescott LF, Freestone S, McAuslane JA. Reassessment of the single intravenous injection method with inulin for measurement of the glomerular filtration rate in man.  Clin Sci (Lond). 1991;  80 167-176
    PubMedGoogle Scholar
  • 36 Prigent A. Monitoring renal function and limitations of renal function tests.  Semin Nucl Med. 2008;  38 32-46
    CrossrefPubMedGoogle Scholar
  • 37 Rehling M. Stability, protein binding and clearance studies of [99 mTc] DTPA. Evaluation of a commercially available dry-kit.  Scand J Clin Lab Invest. 1988;  48 603-609
    PubMedGoogle Scholar
  • 38 Rehling M, Hyldstrup L, Henriksen JH. Arterio-venous concentration difference of [51Cr] EDTA after a single injection in man. Significance of renal function and local blood flow.  Clin Physiol. 1989;  9 279-288
    CrossrefPubMedGoogle Scholar
  • 39 Rehling M, Moller ML, Thamdrup B. et al . Simultaneous measurement of renal clearance and plasma clearance of 99 mTc-labelled diethylenetriaminepenta-acetate, 51Cr-labelled ethylenediaminetetra-acetate and inulin in man.  Clin Sci (Lond). 1984;  66 613-619
    PubMedGoogle Scholar
  • 40 Rehling M, Nielsen SL, Marqversen J. Protein binding of 99 mTc-DTPA, 51Cr-EDTA and 125I-iothalamate.  Nucl Med Commun. 1997;  18 324
    PubMedGoogle Scholar
  • 41 Rehling M, Rabol A. Measurement of glomerular filtration rate in adults: accuracy of five single-sample plasma clearance methods.  Clin Physiol. 1989;  9 171-182
    CrossrefPubMedGoogle Scholar
  • 42 Richard F, Maksud P, Prigent A. Explorations isotopiques de l’appareil urinaire.  Encyclopédie Médico-Chirurgicale. 1996;  34-106-A10 1-10
    PubMedGoogle Scholar
  • 43 Russell CD. Optimum sample times for single-injection, multisample renal clearance methods.  J Nucl Med. 1993;  34 1761-1765
    PubMedGoogle Scholar
  • 44 Russell CD, Bischoff PG, Rowell KL. et al . Quality control of Tc-99 m DTPA for measurement of glomerular filtration: concise communication.  J Nucl Med. 1983;  24 722-727
    PubMedGoogle Scholar
  • 45 Russell CD, Taylor AT, Dubovsky EV. Measurement of renal function with technetium-99 m-MAG3 in children and adults.  J Nucl Med. 1996;  37 588-593
    PubMedGoogle Scholar
  • 46 Sapirstein L, Vidt D, Mandel M. et al . Volumes of distribution and clearances of intravenously injected creatinine in the dog.  Am J Physiol. 1955;  181 330-336
    PubMedGoogle Scholar
  • 47 Skov PE. Glomerular filtration rate in patients with severe and very severe renal insufficiency. Determined by simultaneous inulin, creatinine and 125 iothalamate clearance.  Acta Med Scand. 1970;  187 419-428
    CrossrefPubMedGoogle Scholar
  • 48 Stacy BD, Thorburn GD. Chromium-51 ethylenediaminetetraacetate for estimation of globerular filtration rate.  Science. 1966;  152 1076-1077
    CrossrefPubMedGoogle Scholar
  • 49 Tauxe W, Dubovsky E. Nuclear medicine in clinical urology and nephrology. Norwalk: Appleton-Centring-Crifts; 1985: 49-76
    Google Scholar
  • 50 Tauxe WN, Dubovsky EV, Kidd Jr T. et al . New formulas for the calculation of effective renal plasma flow.  Eur J Nucl Med. 1982;  7 51-54
    PubMedGoogle Scholar
  • 51 Taylor A. Radionuclide renography: a personal approach.  Semin Nucl Med. 1999;  29 102-127
    CrossrefPubMedGoogle Scholar
  • 52 Taylor AT, Lipowska M, Marzilli LG. (99 m)Tc(CO)3(NTA): a (99 m) Tc renal tracer with pharmacokinetic properties comparable to those of (131)I-OIH in healthy volunteers.  J Nucl Med. 2010;  51 391-396
    CrossrefPubMedGoogle Scholar
  • 53 Watson WS. A simple method of estimating glomerular filtration rate.  Eur J Nucl Med. 1992;  19 827
    PubMedGoogle Scholar
  • 54 Zimmer AM, Pavel DG. Rapid miniaturized chromatographic quality-control procedures for Tc-99 m radiopharmaceuticals.  J Nucl Med. 1977;  18 1230-1233
    PubMedGoogle Scholar

Korrespondenzadresse

Doz. Dr. Roland Müller-Suur

Karolinska Institutet Danderyds

Hospital

Department of Clinical Science,

Division of Clinical Physiology

18288 Stockholm

Schweden

Phone: +46/86/55 50

Phone: +46/704/950 411

Fax: +46/86/22 59 35

Email: roland.muller-suur@ki.se

      >